Blog Archive

Αλέξανδρος Γ. Σφακιανάκης

Sunday, July 11, 2021

Human immunodeficiency virus and lymphoma

xlomafota13 shared this article with you from Inoreader

Bull Cancer. 2021 Jul 7:S0007-4551(21)00180-6. doi: 10.1016/j.bulcan.2021.03.014. Online ahead of print.

ABSTRACT

Lymphomas remain a leading cause of morbidity and mortality for HIV-positive patients. The most common lymphomas include diffuse large B-cell lymphoma, Burkitt lymphoma, primary effusion lymphoma, plasmablastic lymphoma and Hodgkin lymphoma. Appropriate approach is determined by lymphoma stage, performans status, comorbidities, histological subtype, status of the HIV disease and immunosuppression. Treatment outcomes have improved due to chemotherapy modalities and effective antiretroviral therapy. This review summarizes epidemiology, pathogenesis, pathology, and current treatment landscape in HIV associated lymphoma.

PMID:34246454 | DOI:10.1016/j.bulcan.2021.03.014

View on the web

No comments:

Post a Comment